These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38848795)

  • 1. Advances and opportunities in process analytical technologies for viral vector manufacturing.
    Sripada SA; Hosseini M; Ramesh S; Wang J; Ritola K; Menegatti S; Daniele MA
    Biotechnol Adv; 2024 Sep; 74():108391. PubMed ID: 38848795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of AAV vectors: A review of analytical techniques and critical quality attributes.
    Kontogiannis T; Braybrook J; McElroy C; Foy C; Whale AS; Quaglia M; Smales CM
    Mol Ther Methods Clin Dev; 2024 Sep; 32(3):101309. PubMed ID: 39234444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New viral vectors for infectious diseases and cancer.
    Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
    Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Online/at-line measurement, analysis and control of product titer and critical product quality attributes (CQAs) during process development.
    Chemmalil L; Prabhakar T; Kuang J; West J; Tan Z; Ehamparanathan V; Song Y; Xu J; Ding J; Li Z
    Biotechnol Bioeng; 2020 Dec; 117(12):3757-3765. PubMed ID: 32776503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of human gene therapy.
    Rubanyi GM
    Mol Aspects Med; 2001 Jun; 22(3):113-42. PubMed ID: 11470139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors.
    Felberbaum RS
    Biotechnol J; 2015 May; 10(5):702-14. PubMed ID: 25800821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques.
    Cole L; Fernandes D; Hussain MT; Kaszuba M; Stenson J; Markova N
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33923984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology outlook for real-time quality attribute and process parameter monitoring in biopharmaceutical development-A review.
    Wasalathanthri DP; Rehmann MS; Song Y; Gu Y; Mi L; Shao C; Chemmalil L; Lee J; Ghose S; Borys MC; Ding J; Li ZJ
    Biotechnol Bioeng; 2020 Oct; 117(10):3182-3198. PubMed ID: 32946122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward biotherapeutic product real-time quality monitoring.
    Guerra A; von Stosch M; Glassey J
    Crit Rev Biotechnol; 2019 May; 39(3):289-305. PubMed ID: 30724608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical Characterization of Adeno-Associated Virus Vectors Using Ion-Exchange Chromatography Coupled to Light Scattering Detectors.
    Wagner C; Innthaler B; Lemmerer M; Pletzenauer R; Birner-Gruenberger R
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality Control Testing, Characterization and Critical Quality Attributes of Adeno-Associated Virus Vectors Used for Human Gene Therapy.
    Wright JF
    Biotechnol J; 2021 Jan; 16(1):e2000022. PubMed ID: 33146911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy.
    Thorne B; Takeya R; Vitelli F; Swanson X
    Adv Biochem Eng Biotechnol; 2018; 165():351-399. PubMed ID: 28289769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for transplantation with viral vectors--how much of the promise has been realised?
    Tan PH; Tan PL; George AJ; Chan CL
    Expert Opin Biol Ther; 2006 Aug; 6(8):759-72. PubMed ID: 16856798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-based gene delivery systems.
    Mah C; Byrne BJ; Flotte TR
    Clin Pharmacokinet; 2002; 41(12):901-11. PubMed ID: 12222993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing clearance of helper adenovirus by a clinical rAAV1 manufacturing process.
    Thorne BA; Quigley P; Nichols G; Moore C; Pastor E; Price D; Ament JW; Takeya RK; Peluso RW
    Biologicals; 2008 Jan; 36(1):7-18. PubMed ID: 17644406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate data analysis in cell gene therapy manufacturing.
    Emerson J; Kara B; Glassey J
    Biotechnol Adv; 2020 Dec; 45():107637. PubMed ID: 32980438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of viral vectors for gene therapy applications.
    Wu N; Ataai MM
    Curr Opin Biotechnol; 2000 Apr; 11(2):205-8. PubMed ID: 10753765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of Adenovirus-Based Vector Heterogeneity.
    Hickey JM; Jacob SI; Tait AS; Vahid FD; Barritt J; Rouse S; Douglas A; Joshi SB; Volkin DB; Bracewell DG
    J Pharm Sci; 2023 Apr; 112(4):974-984. PubMed ID: 36563855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-839. PubMed ID: 28756845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.